EU Lead Factory and CELLIPSE achieve Collaboration Milestone

EU Lead Factory (ELF) and CELLIPSE announced today completion of the 1st phase of their collaboration program to identify hits against an undisclosed innovative therapeutic target that is involved in cytoskeleton regulation.

This project is the continuity of the Limlead project, supported by the CLARA Proof of Concept program.

More information

18/05/2017


Haut de page